666
Views
65
CrossRef citations to date
0
Altmetric
Drug Diversion

The Diversion of Prescription Drugs by Health Care Workers in Cincinnati, Ohio

Pages 255-264 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Mance E. Buttram, Matthew S. Ellis & Yamilka Stivers. (2023) Law enforcement experiences with gabapentin: non-medical use, diversion, and state controlled substances laws. Journal of Substance Use 0:0, pages 1-6.
Read now
Mance E. Buttram & Steven P. Kurtz. (2021) Descriptions of Gabapentin Misuse and Associated Behaviors among a Sample of Opioid (Mis)users in South Florida. Journal of Psychoactive Drugs 53:1, pages 47-54.
Read now
Willem Scholten & Jack E. Henningfield. (2016) Negative outcomes of unbalanced opioid policy supported by clinicians, politicians, and the media. Journal of Pain & Palliative Care Pharmacotherapy 30:1, pages 4-12.
Read now
Harold S Minkowitz & Keith Candiotti. (2015) The role of sublingual sufentanil nanotabs for pain relief. Expert Opinion on Drug Delivery 12:5, pages 845-851.
Read now
R. Terry Furst. (2014) Diffusion and Diversion of Suboxone: An Exploration of Illicit Street Opioid Selling. Journal of Addictive Diseases 33:3, pages 177-186.
Read now
Steven P. Kurtz, Mance E. Buttram & Hilary L. Surratt. (2014) Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA. AIDS Care 26:4, pages 411-415.
Read now
Khary K. Rigg, Steven P. Kurtz & Hilary L. Surratt. (2012) Patterns of prescription medication diversion among drug dealers. Drugs: Education, Prevention and Policy 19:2, pages 145-155.
Read now
Laxmaiah Manchikanti, Ramsin Benyamin, Sukdeb Datta, Ricardo Vallejo & Howard Smith. (2010) Opioids in chronic noncancer pain. Expert Review of Neurotherapeutics 10:5, pages 775-789.
Read now
Adam M. Mitchell & Charlene M. Dewey. (2008) Chronic Pain in Patients with Substance Abuse Disorder: General Guidelines and an Approach to Treatment. Postgraduate Medicine 120:1, pages 75-79.
Read now
Roland N. Okoro. Am I fit to practice? The need for drug-free pharmacists. Journal of Substance Use 0:0, pages 1-3.
Read now

Articles from other publishers (53)

Eilon Caspi, Wei-Lin Xue & Pi-Ju Liu. (2023) Theft of Controlled Substances in Long-Term Care Homes: An Exploratory Study. Journal of Applied Gerontology 42:7, pages 1588-1599.
Crossref
Tom Knight, Bernie May, Don Tyson, Scott McAuley, Pam Letzkus & Sharon Murphy Enright. (2022) Detecting drug diversion in health-system data using machine learning and advanced analytics. American Journal of Health-System Pharmacy 79:16, pages 1345-1354.
Crossref
Sebastian Sattler, Floris van Veen, Fabian Hasselhorn, Guido Mehlkop & Carsten Sauer. (2022) An experimental test of Situational Action Theory of crime causation: Investigating the perception-choice process. Social Science Research 106, pages 102693.
Crossref
Kimberly Walker, Andrew M Harding, Julina Tran, Paul Wembridge, Kent Garrett, Kent MacMillan, Olivia Rofe, Nicholas Jones & David Taylor. (2021) Medication not accounted for in hospital electronic medication administration records: a retrospective observational study. Medical Journal of Australia 216:5, pages 248-254.
Crossref
Buyisile Chibi, Nonhlanhla Yende-Zuma & Tivani P. Mashamba-Thompson. (2020) Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa. PLOS ONE 15:12, pages e0243718.
Crossref
Buyisile Chibi, Neusa Fernanda Torres & Tivani P. Mashamba-Thompson. (2020) Prescription drug diversion, misuse, and abuse among people living with HIV: a scoping review protocol. Systematic Reviews 9:1.
Crossref
Hannah M. Lebovics & Michael D. Mandler. (2020) Chemical Security Education Could Reduce Diversion, Misuse, and Errors in Hospital Settings in the United States. Journal of Chemical Education 97:7, pages 1804-1808.
Crossref
Buyisile Chibi, Neusa F. Torres, Zinhle P. Sokhela & Tivani P. Mashamba-Thompson. (2020) Risk factors for prescription drug diversion among people living with HIV: a systematic scoping review. International Journal of Evidence-Based Healthcare 18:1, pages 5-23.
Crossref
Yaser Mohammed Al-Worafi. 2020. Drug Safety in Developing Countries. Drug Safety in Developing Countries 127 135 .
Yaser Mohammed Al-Worafi. 2020. Drug Safety in Developing Countries. Drug Safety in Developing Countries 7 19 .
B. Chibi, N.F. Torres, Z.P. Sokhela & T.P. Mashamba-Thompson. (2019) Prescription drug diversion among people living with HIV: a systematic scoping review. Public Health 177, pages 26-43.
Crossref
Mance E. Buttram, Steven P. Kurtz, Matthew S. Ellis & Theodore J. Cicero. (2019) Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers. Journal of Substance Abuse Treatment 105, pages 1-4.
Crossref
Mance E. Buttram & Steven P. Kurtz. (2018) Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men. AIDS and Behavior 23:7, pages 1790-1796.
Crossref
Maaike de Vries, Mark Fan, Dorothy Tscheng, Michael Hamilton & Patricia Trbovich. (2019) Clinical observations and a Healthcare Failure Mode and Effect Analysis to identify vulnerabilities in the security and accounting of medications in Ontario hospitals: a study protocol. BMJ Open 9:6, pages e027629.
Crossref
Andreas Hendarto, Andrew M. Harding, Joyce A. Kant, Michelle T. Hunter & David McD Taylor. (2019) Misappropriation of medications and equipment in the emergency department. Australasian Emergency Care 22:2, pages 92-96.
Crossref
Shann Hulme, Caitlin Elizabeth Hughes & Suzanne Nielsen. (2019) What factors contributed to the misconduct of health practitioners? An analysis of Australian cases involving the diversion and supply of pharmaceutical drugs for non‐medical use between 2010 and 2016. Drug and Alcohol Review 38:4, pages 366-376.
Crossref
Steven P. Kurtz, Mance E. Buttram, Zachary R. Margolin & Kevin Wogenstahl. (2019) The diversion of nonscheduled psychoactive prescription medications in the United States, 2002 to 2017. Pharmacoepidemiology and Drug Safety 28:5, pages 700-706.
Crossref
Brian C. Kelly & Mike Vuolo. (2019) Social network ties to nightlife and healthcare professionals and prescription drug misuse among young adults. International Journal of Drug Policy 66, pages 48-56.
Crossref
Juanita A. Draime, Douglas C. Anderson & Timothy S. Anderson. (2018) Description and comparison of medication diversion in pharmacies by pharmacists, interns, and pharmacy technicians. Journal of the American Pharmacists Association 58:3, pages 275-280.
Crossref
Shann Hulme, David Bright & Suzanne Nielsen. (2018) The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. Drug and Alcohol Dependence 186, pages 242-256.
Crossref
Kathryn L. Schwienteck, Guanguan Li, Michael M. Poe, James M. Cook, Matthew L. Banks & S. Stevens Negus. (2017) Abuse-related effects of subtype-selective GABAA receptor positive allosteric modulators in an assay of intracranial self-stimulation in rats. Psychopharmacology 234:14, pages 2091-2101.
Crossref
Steven P. KurtzMance E. Buttram. (2016) Misunderstanding of Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men: Public Health and Policy Implications. LGBT Health 3:6, pages 461-464.
Crossref
Sarah Levin Martin & Clare Desrosiers. (2016) Diversion Alert: 1-Year Evaluation Across Northern New England, 2013–2014. Preventing Chronic Disease 13.
Crossref
Rachel V. Smith, Jennifer R. Havens & Sharon L. Walsh. (2016) Gabapentin misuse, abuse and diversion: a systematic review. Addiction 111:7, pages 1160-1174.
Crossref
Kiyomi Tsuyuki & Hilary L. Surratt. (2015) Antiretroviral Drug Diversion Links Social Vulnerability to Poor Medication Adherence in Substance Abusing Populations. AIDS and Behavior 19:5, pages 869-881.
Crossref
Kiyomi Tsuyuki, Hilary L. Surratt, Maria A. Levi-Minzi, Catherine L. O’Grady & Steven P. Kurtz. (2014) The Demand for Antiretroviral Drugs in the Illicit Marketplace: Implications for HIV Disease Management Among Vulnerable Populations. AIDS and Behavior 19:5, pages 857-868.
Crossref
Sharon R. Sznitman & Yuval Zolotov. (2015) Cannabis for Therapeutic Purposes and public health and safety: A systematic and critical review. International Journal of Drug Policy 26:1, pages 20-29.
Crossref
Mohammed Issa, James Celestin & Ajay D. Wasan. 2014. Practical Management of Pain. Practical Management of Pain 683 694.e3 .
N.I. Cherny, J. Cleary, W. Scholten, L. Radbruch & J. Torode. (2013) The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Annals of Oncology 24, pages xi7-xi13.
Crossref
Shannon M. Smith, Richard C. Dart, Nathaniel P. Katz, Florence Paillard, Edgar H. Adams, Sandra D. Comer, Aldemar Degroot, Robert R. Edwards, David J. Haddox, Jerome H. Jaffe, Christopher M. Jones, Herbert D. Kleber, Ernest A. Kopecky, John D. Markman, Ivan D. Montoya, Charles O’Brien, Carl L. Roland, Marsha Stanton, Eric C. Strain, Gary Vorsanger, Ajay D. Wasan, Roger D. Weiss, Dennis C. Turk & Robert H. Dworkin. (2013) Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain 154:11, pages 2287-2296.
Crossref
Emma Whelan & Mark Asbridge. (2013) The OxyContin crisis: Problematisation and responsibilisation strategies in addiction, pain, and general medicine journals. International Journal of Drug Policy 24:5, pages 402-411.
Crossref
Traci C. Green, Sarah E. Bowman, Madeline Ray, Nickolas Zaller, Robert Heimer & Patricia Case. (2013) Collaboration or Coercion? Partnering to Divert Prescription Opioid Medications. Journal of Urban Health 90:4, pages 758-767.
Crossref
Wanda T. Hilliard, Linda Barloon, Philip Farley, Joseph V. Penn & Angela Koranek. (2013) Bupropion Diversion and Misuse in the Correctional Facility. Journal of Correctional Health Care 19:3, pages 211-217.
Crossref
Hilary L. SurrattSteven P. KurtzTheodore J. CiceroCatherine O’GradyMaria A. Levi-Minzi. (2013) Antiretroviral Medication Diversion Among HIV-Positive Substance Abusers in South Florida. American Journal of Public Health 103:6, pages 1026-1028.
Crossref
Joseph V. Pergolizzi, Christopher G. Gharibo, Jeffrey A. Gudin & Srinivas R. Nalamachu. (2013) Development of Federally Mandated Risk Evaluation and Mitigation Strategies ( REMS ) for Transmucosal Immediate‐Release Fentanyl Products . Pain Practice 13:4, pages 259-263.
Crossref
Willem Scholten. 2013. Cancer Pain. Cancer Pain 249 262 .
. (2012) An Interview With Stephanie K. Trumm, RN, CARN. Journal of Addictions Nursing 23:4, pages 273-275.
Crossref
Elisabeth Frauger, Sandra Nordmann, Veronica Orleans, Vincent Pradel, Vanessa Pauly, Xavier Thirion & Joëlle Micallef. (2011) Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey. Fundamental & Clinical Pharmacology 26:4, pages 549-556.
Crossref
Amelia M. Arria, Laura M. Garnier-Dykstra, Kimberly M. Caldeira, Kathryn B. Vincent & Kevin E. O'Grady. (2011) Prescription Analgesic Use among Young Adults: Adherence to Physician Instructions and Diversion. Pain Medicine 12:6, pages 898-903.
Crossref
BRIONY LARANCE, LOUISA DEGENHARDT, NICK LINTZERIS, ADAM WINSTOCK & RICHARD MATTICK. (2011) Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non‐adherence and aberrant medication‐related behaviours. Drug and Alcohol Review 30:3, pages 236-245.
Crossref
Meagan L Meyer & Tricia A Meyer. (2011) Drug Diversion and Abuse by Health-Care Staff: Facing the Hushed Epidemic. Journal of Pharmacy Technology 27:2, pages 71-75.
Crossref
Hazel Y. Tanga. (2011) Nurse Drug Diversion and Nursing Leader's Responsibilities. JONA's Healthcare Law, Ethics, and Regulation 13:1, pages 13-16.
Crossref
Benedikt Fischer, Meagan Bibby & Martin Bouchard. (2010) The Global Diversion of Pharmaceutical Drugs
Non‐medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 105:12, pages 2062-2070.
Crossref
Gary Reisfield, Gabriel Paulian, Lisa Merlo, Roger Bertholf & George Wilson. (2010) Opioid Prescription Underfilling among Retail Pharmacies. Pain Medicine 11:4, pages 586-590.
Crossref
Jeannette Y. Wick. (2009) Sticky Fingers: Dealing with Employee Theft. The Consultant Pharmacist 24:9, pages 695-699.
Crossref
Louisa DegenhardtBriony K LaranceJames R BellAdam R WinstockNicholas LintzerisRobert L AliNicolas ScheuerRichard P Mattick. (2009) Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist–antagonist formulation. Medical Journal of Australia 191:3, pages 161-165.
Crossref
PETER MILLER & LOUISA DEGENHARDT. (2009) The Global Diversion of Pharmaceutical Drugs series. Addiction 104:3, pages 333-334.
Crossref
Kevin B. Sharer. (2008) Controlled‐Substance Returns in the Operating Suite. AORN Journal 88:2, pages 249-252.
Crossref
John P. Barbuto, George L. White, Christina A. Porucznik & Edward B. Holmes. (2008) Chronic Pain: Second, Do No Harm. American Journal of Physical Medicine & Rehabilitation 87:1, pages 78-83.
Crossref
Aaron M. Gilson, Martha A. Maurer & David E. Joranson. (2007) State Medical Board Members’ Beliefs About Pain, Addiction, and Diversion and Abuse: A Changing Regulatory Environment. The Journal of Pain 8:9, pages 682-691.
Crossref
Stephen E. Lankenau, Bill Sanders, Jennifer Jackson Bloom, Dodi S. Hathazi, Erica Alarcon, Stephanie Tortu & Michael Clatts. (2016) Prevalence and Patterns of Prescription Drug Misuse among Young Ketamine Injectors. Journal of Drug Issues 37:3, pages 717-735.
Crossref
Jane C. Ballantyne & Steven K. LaForge. (2007) Opioid dependence and addiction during opioid treatment of chronic pain. Pain 129:3, pages 235-255.
Crossref
Kent FlemingDeborah BoyleW.J. BillieJesse Carpenter & Connie Linck. (2017) A Novel Approach to Monitoring the Diversion of Controlled Substances: The Role of the Pharmacy Compliance Officer. Hospital Pharmacy 42:3, pages 200-209.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.